Sanritsu Corporation
Sanritsu Corporation (9366.T) Financial Performance & Income Statement Overview
Analyze Sanritsu Corporation (9366.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Sanritsu Corporation (9366.T) Income Statement & Financial Overview
Analyze Sanritsu Corporation’s 9366.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.10B | $5.43B | $5.01B | $4.80B |
| Cost of Revenue | $4.03B | $4.18B | $3.91B | $3.75B |
| Gross Profit | $1.07B | $1.25B | $1.10B | $988.00M |
| Gross Profit Ratio | $0.21 | $0.23 | $0.22 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $894.26M | $899.86M | $794.00M | $852.00M |
| Operating Expenses | $894.26M | $823.90M | $793.00M | $853.00M |
| Total Costs & Expenses | $4.92B | $5.007B | $4.71B | $4.58B |
| Interest Income | $10.11M | $4.59M | $0.00 | $4.02M |
| Interest Expense | $58.27M | $20.45M | $0.00 | $16.71M |
| Depreciation & Amortization | $211.19M | $210.93M | $205.00M | $192.25M |
| EBITDA | $194.51M | $557.86M | $509.00M | $328.25M |
| EBITDA Ratio | $0.04 | $0.10 | $0.10 | $0.07 |
| Operating Income | $172.40M | $422.89M | $305.00M | $135.00M |
| Operating Income Ratio | $0.03 | $0.08 | $0.06 | $0.03 |
| Other Income/Expenses (Net) | -$247.36M | $23.75M | -$173.00M | $49.00M |
| Income Before Tax | -$74.95M | $446.63M | $132.00M | $184.00M |
| Income Before Tax Ratio | -$0.01 | $0.08 | $0.03 | $0.04 |
| Income Tax Expense | -$31.26M | $130.32M | $47.00M | $69.00M |
| Net Income | -$46.92M | $316.59M | $84.00M | $115.04M |
| Net Income Ratio | -$0.009 | $0.06 | $0.02 | $0.02 |
| EPS | -$8.51 | $55.22 | $14.67 | $20.68 |
| Diluted EPS | -$8.51 | $55.22 | $14.66 | $20.19 |
| Weighted Avg Shares Outstanding | $5.60M | $5.73M | $5.60M | $5.56M |
| Weighted Avg Shares Outstanding (Diluted) | $5.60M | $5.73M | $5.73M | $5.70M |
Over the past four quarters, Sanritsu Corporation demonstrated steady revenue growth, increasing from $4.80B in Q1 2024 to $5.10B in Q4 2024. Operating income reached $172.40M in Q4 2024, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $194.51M, reflecting operational efficiency. Net income dropped to -$46.92M, with EPS at -$8.51. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan